{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:52Z","timestamp":1793196592218,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004470","name":"Daewoong Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118386","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:25:30Z","timestamp":1754400330000},"page":"118386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Fexuprazan mitigates NSAID-induced small intestinal injury by restoring intestinal barrier integrity in mice"],"prefix":"10.1016","volume":"190","author":[{"given":"Yunna","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geunhyung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Ju","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunok","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of damage to the gastrointestinal tract from nonsteroidal Anti-Inflammatory drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118386_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53559-7","article-title":"Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing lactobacillus johnsonii","volume":"9","author":"Nadatani","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118386_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5009\/gnl20079","article-title":"A nationwide cohort study shows a Sex-Dependent change in the trend of peptic ulcer bleeding incidence in korea between 2006 and 2015","volume":"15","author":"Kim","year":"2021","journal-title":"Gut Liver"},{"issue":"5","key":"10.1016\/j.biopha.2025.118386_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-019-01657-8","article-title":"Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review","volume":"55","author":"Watanabe","year":"2020","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118386_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000452356","article-title":"Microbiota plays a key role in Non-Steroidal Anti-Inflammatory Drug-Induced small intestinal damage","volume":"95","author":"Otani","year":"2017","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent Potassium-competitive acid blockers: a new era for the treatment of Acid-related diseases","volume":"24","author":"Oshima","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7704\/kjhugr.2023.0040","article-title":"History and pharmacological mechanism of gastric Acid-suppressive drugs","volume":"23","author":"Yeom","year":"2023","journal-title":"Korean J. Helicobacter Up. Gastrointest. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118386_bib8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","article-title":"Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis","volume":"141","author":"Wallace","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118386_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000339882","article-title":"In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine","volume":"86","author":"Lim","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.biopha.2025.118386_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114099","article-title":"Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia\/reperfusion injury in rats","volume":"178","author":"L\u00e1szl\u00f3","year":"2020","journal-title":"Biochem Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118386_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949332","article-title":"Autotaxin loss accelerates intestinal inflammation by suppressing TLR4-mediated immune responses","volume":"21","author":"Kim","year":"2020","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.biopha.2025.118386_bib12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/jgh.15868","article-title":"Exacerbation of non-steroidal anti-inflammatory drug-induced enteropathy in C-C chemokine receptor type 7-deficient mice","volume":"37","author":"Yamaguchi","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118386_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5217\/ir.2017.15.4.446","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy","volume":"15","author":"Shin","year":"2017","journal-title":"Intest Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118386_bib14","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000588","article-title":"Proton pump inhibitors increase the risk of nonsteroidal Anti-inflammatory Drug-Related Small-Bowel injury: a systematic review with Meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118386_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5009\/gnl220457","article-title":"Efficacy and safety of fexuprazan in patients with acute or chronic gastritis","volume":"17","author":"Kim","year":"2023","journal-title":"Gut Liver"},{"issue":"28","key":"10.1016\/j.biopha.2025.118386_bib16","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.3748\/wjg.v28.i28.3608","article-title":"Potassium-competitive acid blockers and gastroesophageal reflux disease","volume":"28","author":"Leowattana","year":"2022","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.biopha.2025.118386_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114290","article-title":"Revaprazan prevented indomethacin-induced intestinal damages by enhancing tight junction related mechanisms","volume":"182","author":"Han","year":"2020","journal-title":"Biochem Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/mi.2015.89","article-title":"Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy","volume":"9","author":"Higashimori","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118386_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajpath.2012.03.039","article-title":"High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4","volume":"181","author":"Nadatani","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118386_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/gut.2007.125963","article-title":"Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent","volume":"57","author":"Watanabe","year":"2008","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biopha.2025.118386_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118386_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of Interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2025.118386_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118386_bib24","first-page":"1512969","article-title":"Functions of macrophages in the maintenance of intestinal homeostasis","author":"Wang","year":"2019","journal-title":"J. Immunol. Res 2019"},{"issue":"6","key":"10.1016\/j.biopha.2025.118386_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060786","article-title":"Risks related to the use of Non-Steroidal Anti-Inflammatory drugs in Community-Acquired pneumonia in adult and pediatric patients","volume":"8","author":"Voiriot","year":"2019","journal-title":"J. Clin. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-013-1779-3","article-title":"PECAM-1: regulator of endothelial junctional integrity","volume":"355","author":"Privratsky","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"3-4","key":"10.1016\/j.biopha.2025.118386_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lfs.2010.06.001","article-title":"PECAM-1: conflicts of interest in inflammation","volume":"87","author":"Privratsky","year":"2010","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.41.3.344","article-title":"Mitochondrial damage: a possible mechanism of the \"topical\" phase of NSAID induced injury to the rat intestine","volume":"41","author":"Somasundaram","year":"1997","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.biopha.2025.118386_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081909","article-title":"The intestinal barrier and current techniques for the assessment of gut permeability","volume":"9","author":"Schoultz","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.biopha.2025.118386_bib30","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.biopha.2025.118386_bib31","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1039\/C9FO01307E","article-title":"Processed aloe vera gel attenuates non-steroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by enhancing mucin expression","volume":"10","author":"Kim","year":"2019","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.biopha.2025.118386_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/phrs.1999.0550","article-title":"Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats","volume":"40","author":"Konaka","year":"1999","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118386_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118185","article-title":"Restoration of intestinal barrier function by fexuprazan, a potassium-competitive acid blocker, in Caco-2 cells and its higher gastrointestinal distribution in rats","volume":"188","author":"Jeon","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118386_bib34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41556-018-0201-5","article-title":"Life, death and autophagy","volume":"20","author":"Doherty","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118386_bib35","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1080\/15548627.2021.2016233","article-title":"AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability","volume":"18","author":"Ganapathy","year":"2022","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.biopha.2025.118386_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmed.2009.01.002","article-title":"When apoptosis meets autophagy: deciding cell fate after trauma and sepsis","volume":"15","author":"Hsieh","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118386_bib37","first-page":"6859","article-title":"Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and beclin 1 in A549 human lung cancer cells","volume":"17","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2025.118386_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070674","article-title":"A comprehensive review of autophagy and its various roles in infectious, Non-Infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy","volume":"8","author":"Khandia","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2025.118386_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15548627.2022.2071381","article-title":"Proteotoxic stress disrupts epithelial integrity by inducing MTOR sequestration and autophagy overactivation","volume":"19","author":"Cheng","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.118386_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155791","article-title":"Cinnamaldehyde alleviates aspirin-induced gastric mucosal injury by regulating pi3k\/akt pathway-mediated apoptosis, autophagy and ferroptosis","volume":"132","author":"Yan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118386_bib41","article-title":"Gut microbiota in NSAID enteropathy: new insights from inside","volume":"11","author":"Wang","year":"2021","journal-title":"Front Cell Infect. Microbiol"},{"issue":"8","key":"10.1016\/j.biopha.2025.118386_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1348-0421.1996.tb01108.x","article-title":"Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug","volume":"40","author":"Uejima","year":"1996","journal-title":"Microbiol Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118386_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102271","article-title":"Proton pump inhibitors and Oral-Gut microbiota: from mechanism to clinical significance","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"issue":"Pt 7","key":"10.1016\/j.biopha.2025.118386_bib44","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1099\/ijs.0.055095-0","article-title":"Gordonibacter urolithinfaciens sp. Nov., a urolithin-producing bacterium isolated from the human gut","volume":"64","author":"Selma","year":"2014","journal-title":"Int J. Syst. Evol. Microbiol"},{"issue":"20","key":"10.1016\/j.biopha.2025.118386_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204441","article-title":"Pharmacological effects of urolithin a and its role in muscle health and performance: current knowledge and prospects","volume":"15","author":"Zhao","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2025.118386_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.mat.0000191345.45735.00","article-title":"In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease","volume":"52","author":"Ranganathan","year":"2006","journal-title":"Asaio. j."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:36:50Z","timestamp":1772786210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S0753332225005803"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118386","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fexuprazan mitigates NSAID-induced small intestinal injury by restoring intestinal barrier integrity in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118386"}}